James N Herron
Overview
Explore the profile of James N Herron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galloway D, Li J, Nguyen N, Falkenberg F, Henning L, Krile R, et al.
Front Immunol
. 2024 Apr;
15:1277526.
PMID: 38605961
This study evaluated a depot-formulated cytokine-based adjuvant to improve the efficacy of the recombinant F1V (rF1V) plague vaccine and examined the protective response following aerosol challenge in a murine model....
2.
Galloway D, Nguyen N, Li J, Houston N, Gregersen G, Williamson E, et al.
Front Immunol
. 2022 Nov;
13:1017385.
PMID: 36389793
The development of a safe and effective vaccine against , the causative organism for plague disease, remains an important global health priority. Studies have demonstrated effective immune-based protection against plague...
3.
Kaur I, Kosak K, Terrazas M, Herron J, Kern S, Boucher K, et al.
Pharm Res
. 2014 Oct;
32(4):1395-406.
PMID: 25330743
Purpose: O(2)-(2,4-dinitrophenyl)1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] or JS-K is a nitric oxide-producing prodrug of the arylated diazeniumdiolate class with promising anti-tumor activity. JS-K has challenging solubility and stability properties. We aimed to characterize and...
4.
Hawe A, Rispens T, Herron J, Jiskoot W
J Pharm Sci
. 2010 Oct;
100(4):1294-305.
PMID: 20957745
Fluorescent dyes, for example, 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid dipotassium salt (bis-ANS) are extensively used to detect nonnative protein structures in therapeutic protein products, for example, during formulation development by monitoring the greatly...
5.
Duer R, Lund R, Tanaka R, Christensen D, Herron J
Anal Chem
. 2010 Oct;
82(21):8856-65.
PMID: 20945920
A new microarray technology is described for rapid, inexpensive, multiplex diagnostics assays. Referred to as "in-plane parallel scanning" (IPPS), this technology replaces expensive laser scanning with a grid of 100-μm-wide...
6.
Christensen D, Herron J
Methods Mol Biol
. 2009 Jan;
503:239-58.
PMID: 19151945
The use of Charge Coupled Device (CCD) detectors as an integral part of a biosensing system has become widespread in recent years due to several advantages of this type of...
7.
Suhonen M, Li S, Higuchi W, Herron J
J Pharm Sci
. 2008 Feb;
97(10):4278-93.
PMID: 18240299
The objective was to evaluate stratum corneum lipid liposomes (SCLLs) prepared from commercial lipids as a convenient model system for studying the mechanisms of chemical permeation enhancers. Liposomes prepared from...
8.
Guo J, Elzinga P, Hageman M, Herron J
J Pharm Sci
. 2007 Sep;
97(6):2080-90.
PMID: 17879292
A rapid-throughput screening assay was developed to estimate the salt solubility parameter, K(SP), with a minimal quantity of drug. This assay allows for early evaluation of salt limited solubility with...
9.
Guo J, Elzinga P, Hageman M, Herron J
J Pharm Sci
. 2007 Aug;
97(4):1427-42.
PMID: 17724660
A rapid solubility-screening assay was developed with a focus on Biopharmaceutic Classification Scheme (BCS) class II drug solubility in animal and simulated human gastrointestinal (GI) fluids. The assay enables biologically...
10.
Cavenaugh J, Wang H, Sha J, Hansen C, Papangkorn K, Smith R, et al.
Pharm Res
. 2004 Sep;
21(8):1480-8.
PMID: 15359585
Purpose: To determine whether a vaccine consisting of an idiotope peptide mimic of the third complementarity-determining region of the immunoglobulin heavy chain (CDR-H3) is an effective substitute for its parent...